Skip to main content
Frank Litvack, MD, Cardiology, Beverly Hills, CA

FrankLitvackMD

Cardiology Beverly Hills, CA

Adult Congenital Heart Disease, Interventional Cardiology

Professor, Medicine, UCLA School of Medicine

Dr. Litvack is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Litvack's full profile

Already have an account?

  • Office

    8840 Wilshire Blvd
    2nd floor
    Beverly Hills, CA 90211
    Phone+1 213-380-7130
    Fax+1 310-967-1744

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1982 - 1985
  • McGill University Faculty Medicine Hospital
    McGill University Faculty Medicine HospitalInternal Medicine, 1979 - 1982
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1979

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1988 - Present
  • CA State Medical License
    CA State Medical License 1982 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • V-wave Raises $98m to Support Further Development of Cardiac Shunt
    V-wave Raises $98m to Support Further Development of Cardiac ShuntSeptember 23rd, 2020
  • Billionaire Efrem Kamen Pulled Cash from Otonomy Inc (OTIC) and Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Welcoming Gilead Sciences, Inc. (GILD)
    Billionaire Efrem Kamen Pulled Cash from Otonomy Inc (OTIC) and Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Welcoming Gilead Sciences, Inc. (GILD)September 5th, 2017
  • V-wave Scores $28 Mln Series B
    V-wave Scores $28 Mln Series BJanuary 11th, 2016
  • Join now to see all

Professional Memberships